N/A
Completed N=46
Breath Analysis Based Disease Biomarkers
Source: ClinicalTrials.gov NCT04341012 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
Nov 2024
Primary outcomePrimary: Breath Volatile Organic Compound Profiles — 11; 35 Participants
Summary
The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Breath Volatile Organic Compound Profiles |
11; 35 | — |
Eligibility Criteria
Inclusion Criteria
- Able to provide informed consent
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT04341012). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.